Skip to main content
. 2023 Mar 1;10(4):ofad111. doi: 10.1093/ofid/ofad111

Table 1.

Baseline Characteristics for Study Participants (Analysis Set)

Characteristics CD Cohort LTCF Cohort
Season 1
N 1251 664
Age at enrollment, mean ± SD (years) 65.1 ± 8.8 82.7 ± 8.5
Age Group at Enrollment (Years)
 50–59 382 (30.5%)
 60–64 238 (19.0%)
 65–69 242 (19.3%) 59 (8.9%)
 70–79 315 (25.2%) 172 (25.9%)
≥ 80 74 (5.9%) 433 (65.2%)
Female sex, n (%) 766 (61.2%) 430 (64.8%)
Race, n (%)
 White-Caucasian/European heritage 1245 (99.5%) 629 (94.7%)
 Other 6 (0.5%) 35 (5.3%)
Educational Status, n (%)
 None 2 (0.2%) 14 (2.1%)
 Elementary 307 (24.6%) 177 (26.7%)
 High School 340 (27.2%) 228 (34.3%)
 Vocational/Technical 291 (23.3%) 67 (10.1%)
 College/University 309 (24.7%) 178 (26.8%)
 Missing 2 (0.1%) 0 (0.0%)
Smoking Status, n (%)
 Current smoker 210 (16.8%) 48 (7.2%)
 Former smoker 406 (32.5%) 200 (30.1%)
 Never smoked 635 (50.8%) 416 (62.7%)
Frailty Status*
 Fit 909 (72.7%) 39 (5.9%)
 Prefrail 232 (18.5%) 79 (11.9%)
 Frail 105 (8.4%) 419 (63.1%)
 Missing 5 (0.4%) 127 (19.1%)
Any past or current relevant medical conditions, n (%) 1167 (93.3%) 660 (99.4%)
Any Current Medical Conditions, n (%) 1139 (91.0%) 659 (99.2%)
 Vascular disorders 689 (55.1%) 530 (79.8%)
 Metabolism and nutrition disorders 545 (43.6%) 388 (58.4%)
 Diabetes 192 (15.3%) 176 (26.5%)
 Obesity 71 (5.7%) 20 (3.0%)
 Respiratory, thoracic, and mediastinal disorders 249 (19.9%) 170 (25.6%)
 Chronic obstructive pulmonary disease 67 (5.4%) 92 (13.9%)
 Asthma 83 (6.6%) 35 (5.3%)
 Cardiac disorders 189 (15.1%) 287 (43.2%)
 Left ventricular failure 4 (0.3%) 1 (0.2%)
 Coronary artery disease 21 (1.7%) 25 (3.8%)
 Renal and urinary disorders 112 (9.0%) 181 (27.3%)
 Neoplasms benign, malignant, and unspecified (including cysts and polyps) 68 (5.4%) 45 (6.8%)
 Hepatobiliary disorders 47 (3.8%) 15 (2.3%)
Received Any Influenza/Pneumococcal/Pertussis Vaccination, n (%) 796 (63.6%) 496 (74.7%)
 Influenza vaccination 711 (56.8%) 480 (72.3%)
 Pneumococcal vaccination 247 (19.7%) 208 (31.3%)
 Pertussis vaccination 177 (14.1%) 21 (3.2%)
Season 2
N 1223 494
Age at enrollment, mean ± SD (years) 66.5 ± 8.8 83.4 ± 8.4
Age Group at Enrollment (Years)
 50–59 294 (24%)
 60–64 233 (19.1%)
 65–69 255 (20.9%) 34 (6.9%)
 70–79 345 (28.2%) 126 (25.5%)
 ≥80 96 (7.8%) 334 (67.6%)
Female sex, n (%) 749 (61.2%) 318 (64.4%)
Race, n (%)
 White-Caucasian/European heritage 1218 (99.6%) 464 (93.9%)
 Other 5 (0.4%) 30 (6.1%)
Any past or current relevant medical conditions, n (%) 1154 (94.4%) 491 (99.4%)
Received Any Influenza/Pneumococcal/Pertussis Vaccination, n (%) 838 (68.5%) 410 (83.0%)
 Influenza vaccination 758 (62.0%) 405 (82%)
 Pneumococcal vaccination 268 (21.9%) 165 (33.4%)
 Pertussis vaccination 182 (14.9%) 17 (3.4%)

Abbreviations: CD, community-dwelling; LTCF, long-term care facility; N, number of participants in the analysis set; SD, standard deviation; n (%), number (percentage) of participants in a given category.

NOTE: Frailty status was determined based on the short physical performance battery total scores: fit 10–12 points; prefrail 8–9 points; frail ≤7 points.